Cargando…
NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Via Medica
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007476/ https://www.ncbi.nlm.nih.gov/pubmed/34897639 http://dx.doi.org/10.5603/CJ.a2021.0158 |
| _version_ | 1784686857397731328 |
|---|---|
| author | Piepiorka-Broniecka, Marta Michalski, Tomasz A. Figatowski, Tomasz Wojtowicz, Andrzej Jurowiecki, Jarosław Stanska, Aleksandra Rogowski, Jan Jaguszewski, Milosz J. |
| author_facet | Piepiorka-Broniecka, Marta Michalski, Tomasz A. Figatowski, Tomasz Wojtowicz, Andrzej Jurowiecki, Jarosław Stanska, Aleksandra Rogowski, Jan Jaguszewski, Milosz J. |
| author_sort | Piepiorka-Broniecka, Marta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9007476 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Via Medica |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90074762022-04-14 NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement Piepiorka-Broniecka, Marta Michalski, Tomasz A. Figatowski, Tomasz Wojtowicz, Andrzej Jurowiecki, Jarosław Stanska, Aleksandra Rogowski, Jan Jaguszewski, Milosz J. Cardiol J Clinical Cardiology Via Medica 2022-04-07 /pmc/articles/PMC9007476/ /pubmed/34897639 http://dx.doi.org/10.5603/CJ.a2021.0158 Text en Copyright © 2022 Via Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially |
| spellingShingle | Clinical Cardiology Piepiorka-Broniecka, Marta Michalski, Tomasz A. Figatowski, Tomasz Wojtowicz, Andrzej Jurowiecki, Jarosław Stanska, Aleksandra Rogowski, Jan Jaguszewski, Milosz J. NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement |
| title | NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement |
| title_full | NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement |
| title_fullStr | NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement |
| title_full_unstemmed | NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement |
| title_short | NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement |
| title_sort | noac versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement |
| topic | Clinical Cardiology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007476/ https://www.ncbi.nlm.nih.gov/pubmed/34897639 http://dx.doi.org/10.5603/CJ.a2021.0158 |
| work_keys_str_mv | AT piepiorkabronieckamarta noacversuswarfarininthetreatmentofatrialfibrillationduringthefirstthreemonthsafterbioprostheticaorticvalvereplacement AT michalskitomasza noacversuswarfarininthetreatmentofatrialfibrillationduringthefirstthreemonthsafterbioprostheticaorticvalvereplacement AT figatowskitomasz noacversuswarfarininthetreatmentofatrialfibrillationduringthefirstthreemonthsafterbioprostheticaorticvalvereplacement AT wojtowiczandrzej noacversuswarfarininthetreatmentofatrialfibrillationduringthefirstthreemonthsafterbioprostheticaorticvalvereplacement AT jurowieckijarosław noacversuswarfarininthetreatmentofatrialfibrillationduringthefirstthreemonthsafterbioprostheticaorticvalvereplacement AT stanskaaleksandra noacversuswarfarininthetreatmentofatrialfibrillationduringthefirstthreemonthsafterbioprostheticaorticvalvereplacement AT rogowskijan noacversuswarfarininthetreatmentofatrialfibrillationduringthefirstthreemonthsafterbioprostheticaorticvalvereplacement AT jaguszewskimiloszj noacversuswarfarininthetreatmentofatrialfibrillationduringthefirstthreemonthsafterbioprostheticaorticvalvereplacement |